We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+21.99%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$137M
AUM Growth
+$6.74M
Cap. Flow
-$9.94M
Cap. Flow %
-7.27%
Top 10 Hldgs %
36.21%
Holding
88
New
23
Increased
19
Reduced
22
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 40.81%
2 Consumer Discretionary 12.34%
3 Communication Services 11.33%
4 Industrials 11.3%
5 Financials 4.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
1
Meta Platforms (Facebook)
META
$1.51T
$7.26M 5.3%
93,000
+7,500
+9% +$573K
RCPT
2
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$6.31M 4.61%
51,500
+27,000
+110% +$2.73M
AGN
3
DELISTED
Allergan plc
AGN
$5.39M 3.94%
20,925
+915
+5% +$229K
AAP icon
4
Advance Auto Parts
AAP
$3.37B
$5.34M 3.9%
33,500
+8,500
+34% +$1.25M
DOOR
5
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$5.19M 3.8%
84,500
+500
+0.6% +$28.2K
MYCC
6
DELISTED
ClubCorp Holdings, Inc.
MYCC
$4.38M 3.2%
244,500
+1,500
+0.6% +$28.3K
ILMN icon
7
Illumina
ILMN
$29.4B
$4.08M 2.99%
22,745
+8,353
+58% +$1.47M
GOOG icon
8
Alphabet (Google) Class C
GOOG
$3.9T
$3.95M 2.89%
149,910
-18,050
-11% -$484K
VSI
9
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
$3.89M 2.84%
80,000
+1,000
+1% +$45.9K
ACAD icon
10
Acadia Pharmaceuticals
ACAD
$4.25B
$3.76M 2.75%
118,500
-33,500
-22% -$950K
ABBV icon
11
AbbVie
ABBV
$458B
$3.76M 2.75%
57,399
-14,601
-20% -$921K
CSTE icon
12
Caesarstone
CSTE
$72.3M
$3.31M 2.42%
55,350
-150
-0.3% -$8.52K
UHS icon
13
Universal Health Services
UHS
$9.43B
$3.08M 2.25%
27,660
-840
-3% -$88.2K
AGIO icon
14
Agios Pharmaceuticals
AGIO
$2.16B
$3.02M 2.21%
27,000
-27,000
-50% -$2.41M
HAPN
15
Happen Inc
HAPN
$2.08B
$2.91M 2.13%
+23,000
New +$2.9M
TDG icon
16
TransDigm Group
TDG
$69.2B
$2.78M 2.03%
14,160
+100
+0.7% +$18.9K
OCR
17
DELISTED
OMNICARE INC
OCR
$2.41M 1.76%
33,000
-1,000
-3% -$67.9K
CELG
18
DELISTED
Celgene Corp
CELG
$2.4M 1.76%
21,500
-11,500
-35% -$1.21M
AGN
19
DELISTED
Allergan Inc
AGN
$2.4M 1.76%
11,300
-2,200
-16% -$437K
DRII
20
DELISTED
DIAMOND RESORTS INTL, INC
DRII
$2.32M 1.69%
83,000
+28,000
+51% +$689K
TRUE
21
DELISTED
TrueCar
TRUE
$2.22M 1.62%
97,000
+47,500
+96% +$931K
AVNR
22
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$2.18M 1.59%
128,674
-6,326
-5% -$89K
VSI
23
DELISTED
Vitamin Shoppe Inc.
VSI
$2.14M 1.56%
44,000
+14,000
+47% +$642K
SHPG
24
DELISTED
Shire pic
SHPG
$2.13M 1.55%
10,000
+4,100
+69% +$870K
LULU icon
25
lululemon athletica
LULU
$13B
$2.09M 1.53%
+37,500
New +$1.71M

Similar funds

Atika Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Atika Capital Management held 88 positions worth $137M, up 5.2% from $130M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Atika Capital Management withdrew a net $9.94M in Q4 2014, closing 20 positions and reducing 22 holdings. Its most notable exit was Martin Marietta Materials, an estimated $3.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Atika Capital Management opened a new position in Happen Inc worth $2.91M.

  • Atika Capital Management's largest Q4 2014 buy was Happen Inc: 23,000 shares worth $2.91M.
  • Atika Capital Management added most to RECEPTOS INC COM STK (DE) in Q4 2014, an estimated $2.73M increase.
  • Atika Capital Management's biggest Q4 2014 reduction was Agios Pharmaceuticals, cutting an estimated $2.41M.
  • Atika Capital Management fully exited Martin Marietta Materials in Q4 2014, selling an estimated $3.69M.
  • Atika Capital Management's ten largest holdings make up 36% of its $137M portfolio in Q4 2014.
  • Atika Capital Management opened 23 new positions and closed 20 in Q4 2014.
  • Atika Capital Management's portfolio value rose 5.2% quarter-over-quarter to $137M.

Based on Atika Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.